Characteristics of Patients and Expanded NK Cells for Clinical Trial

PatientBreedAgeSexWeight (kg)Injection #1a(× 106)Viability (%)Injection #2a(× 106)Viability (%)
1Black Lab14.8M29.63079.30.31.0
2St. Bernard9.1M5914.380.211.0496.0
3Shepherd Mix9.1M23.839298.9155100.0
4Shepherd Mix5.8M46114.6394.8139.799.0
5St. Bernard1.2F57.675.9398.626.797.2
6St. Bernard6.3M94129.599.286.999.2
7Pyrenees7.5F57.1139.595.094.596.0
8Doberman5.0M662570.028076.0
9Retriever Mix8.9F3218095.017594.0
10Rhodesian Ridgeback10.2F35.111595.01795.0

aExpanded NK cells were documented to be LPS and Mycoplasma negative prior to adoptive transfer